Nykode Therapeutics As Stock Forecast

Buy or Hold candidate since Jul 24, 2026 Gain 3.45%

The Nykode Therapeutics As stock price fell by -0.90% on the last day (Monday, 10th Aug 2026) from kr3.33 to kr3.30. During the last trading day the stock fluctuated 1.82% from a day low at kr3.30 to a day high of kr3.36. The price has fallen in 6 of the last 10 days but is still up by 2.64% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -226 thousand shares and in total, 341 thousand shares were bought and sold for approximately kr1.13 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Nykode Therapeutics As stock with a 90% probability to be traded between kr2.66 and kr3.45 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

NYKD.OL Signals & Forecast

The Nykode Therapeutics As stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately kr3.31. On a fall, the stock will find some support from the long-term average at approximately kr3.10. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Wednesday, August 05, 2026, and so far it has risen 2.80%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Nykode Therapeutics As stock

Nykode Therapeutics As finds support from accumulated volume at kr3.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved kr0.0600 between high and low, or 1.82%. For the last week the stock has had daily average volatility of 3.97%.

Our recommended stop-loss: kr3.15 (-4.65%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (NYKD.OL) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Nykode Therapeutics As to open at kr3.32, and during the day (based on 14 day Average True Range), to move between kr3.22 and kr3.38, which gives a possible trading interval of +/-kr0.160 (+/-4.98%) up or down from last closing price. If Nykode Therapeutics As takes out the full calculated possible swing range there will be an estimated 4.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at kr3.36 (1.82%) than the support at kr3.19 (3.33%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Nykode Therapeutics As stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Nykode Therapeutics As stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.195 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - kr3.32 ( 0.606%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk